p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance

Molecular and Cellular Biology

Volumn 24, Issue 13, 2004, Pages 5967-5977

  Razak, Zaineb R Abdul ^a   Varkonyi, Robert J ^a   Kulp McEliece, Michelle ^a,b   Caslini, Corrado ^a   Testa, Joseph R ^a   Murphy, Maureen E ^a   Broccoli, Dominique ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b Gwynedd Mercy University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL GROWTH; CHROMATIN; DNA DAMAGE; DNA RECOMBINATION; DNA SYNTHESIS INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TELOMERE; TRANSACTIVATION;

ALLELES; CELL DIVISION; CELL LINE; DNA REPLICATION; HUMANS; MUTATION; RECOMBINATION, GENETIC; S PHASE; TELOMERE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942735134     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.13.5967-5977.2004     Document Type: Article

References (66)

1. Auersperg, N., S. Maines-Bandiera, J. Booth, H. Lynch, A. Godwin, and T. Hamilton. 1995. Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family history of ovarian cancer. Am. J. Obstet. Gynecol. 173:558-565.
2. Bayne, R. A., D. Broccoli, M. H. Taggart, E. J. Thomson, C. J. Farr, and H. J. Cooke. 1994. Sandwiching of a gene within 12 kb of a functional telomere and alpha satellite does not result in silencing. Hum. Mol. Genet. 3:539-546.
3. Bertrand, P., D. Rouillard, A. Boalet, C. Levalois, T. Soussi, and B. S. Lopez. 1997. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14:1117-1122.
4. Boehden, G. S., N. Akyuz, K. Roemer, and L. Wiesmuller. 2003. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene 22:4111-4117.
5. Broccoli, D., L. A. Godley, L. A. Donehower, H. E. Varmus, and T. de Lange. 1996. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16:3765-3772.
6. Broccoli, D., A. Smogorzewska, L. Chong, and T. de Lange. 1997. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:231-235.
7. Bryan, T. M., A. Englezou, L. Dalla-Pozza, M. A. Dunham, and R. R. Reddel. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-1274.
8. Bryan, T. M., A. Englezou, J. Gupta, S. Bacchetti, and R. R. Reddel. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240-4248.
9. Cadwell, C., and G. P. Zambetti. 2001. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277:15-30.
10. Cerone, M. A., J. A. Londono-Vallejo, and S. Bacchetti. 2001. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10:1945-1952.
11. Chang, S., C. M. Khoo, M. L. Naylor, R. S. Maser, and R. A. DePinho. 2003. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev. 17:88-100.
12. Chen, Q., A. Ijpma, and C. W. Greider. 2001. Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol. Cell. Biol. 21:1819-1827.
13. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
14. d'Adda di Fagagna, F., P. M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, T. Von Zglinicki, G. Saretzki, N. P. Carter, and S. P. Jackson. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:394-198.
15. Dudenhoffer, C., M. Kurth, F. Janus, W. Deppert, and L. Wiesmuller. 1999. Dissociation of the recombination control and the sequence specific transactivation function of p53. Oncogene 18:5773-5784.
16. Dudenhoffer, C., G. Rohaly, K. Will, W. Deppert, and L. Wiesmuller. 1998. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol. 18:5332-5342.
17. Dunham, M. A., A. A. Neymann, C. L. Fasching, and R. R. Reddel. 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26:447-450.
18. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
19. Foddis, R., A. De Rienzo, D. Broccoli, M. Bocchetta, E. Stekala, P. Rizzo, A. Tosolini, J. V. Grobelny, S. C. Jhanwar, H. I. Pass, J. R. Testa, and M. Carbone. 2002. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 21:1434-1442.
20. Ford, L. P., Y. Zou, K. Pongracz, S. M. Gryaznov, J. W. Shay, and W. E. Wright. 2001. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276:32198-32203.
21. Gottifredi, V., S. Shieh, Y. Taya, and C. Prives. 2001. p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc. Natl. Acad. Sci. USA 98:1036-1041.
22. 2/M phase of the cell cycle. J. Cell Sci. 113:4577-4585.
23. Grobelny, J. V., M. Kulp-McEliece, and D. Broccoli. 2001. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening to telomeres (ALT) pathway. Hum. Mol. Genet. 10:1953-1961.
24. Hammond, E. M., N. C. Denko, M. J. Dorie, R. T. Abraham, and A. J. Giaccia. 2002. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22:1834-1843.
25. Hemann, M. T., M. A. Strong, L.-Y. Hao, and C. W. Greider. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77.
26. Henson, J. D., A. A. Neumann, T. R. Yeager, and R. R. Reddel. 2002. Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610.
27. Jimenez, G. S., M. Nister, J. M. Stommel, M. Beeche, E. A. Barcarse, X. Q. Zhang, S. O'Gorman, and G. M. Wahl. 2000. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26:37-43.
28. Karlseder, J., D. Broccoli, Y. Dai, S. Hardy, and T. de Lange. 1999. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325.
29. Lee, S., L. Cavallo, and J. Griffith. 1997. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272:7532-7539.
30. Lee, S., B. Elenbaas, A. Levine, and J. Griffith. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020.
31. Lin, J., J. Chen, B. Elenbaas, and A. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.
32. Lundblad, V., and E. H. Blackburn. 1993. An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73:347-360.
33. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
34. Mekeel, K. L., W. Tang, L. A. Kachnic, C. M. Luo, J. S. DeFrank, and S. N. Powell. 1997. Inactivation of p53 results in high rates of homologous recombination. Oncogene 14:1847-1857.
35. Michalovitz, D., D. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
36. Miller, D. A., V. Sharma, and A. R. Mitchell. 1988. A human-derived probe, p82H, hybridizes to the centromeres of gorilla, chimpanzee, and orangutan. Chromosoma 96:270-274.
37. Nelson, D. M., X. Ye, C. Hall, R. Santos, T. Ma, G. D. Kao, T. J. Yen, J. W. Harper, and P. D. Adams. 2002. Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity. Mol. Cell. Biol. 22:7459-7472.
38. Niida, H., Y. Shinkai, M. P. Hande, T. Matsumoto, S. Takehara, M. Tachibana, M. Oshimura, P. M. Lansdorp, and Y. Furuichi. 2000. Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol. Cell. Biol. 20:4114-4127.
39. Opitz, O. G., Y. Suliman, W. M. Hahn, H. Harada, H. E. Blum, and A. K. Rustig. 2001. Cyclin Dl overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J. Clin. Investig. 108:725-732.
40. Perrem, K., L. M. Colgin, A. A. Neumann, T. R. Yeager, and R. R. Reddel. 2001. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21:3862-3875.
41. Quignon, F., F. DeBels, M. Koken, J. Feunteum, J. C. Ameisen, and H. de The. 1998. PML induces a novel caspase-independent death process. Nat. Genet. 20:259-265.
42. Reddel, R. R., T. M. Bryan, and J. P. Murnane. 1997. Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Moscow) 62:1254-1262.
43. Roemer, K., and N. Mueller-Lantzsch. 1996. p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis. Oncogene 12:2069-2079.
44. Sabbatini, P., J. Lin, A. J. Levine, and E. White. 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9:2184-2192.
45. Saintigny, Y., D. Rouillard, B. Chaput, T. Soussi, and B. S. Lopez. 1999. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 18:3553-3563.
46. Sang, B. C., J. Y. Chen, J. Minna, and M. S. Barbosa. 1994. Distinct regions of p53 have a differential role in transcriptional activation and repression functions. Oncogene 9:853-859.
47. Seeler, J. S., and A. Dejean. 1999. The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9:362-367.
48. Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:787-791.
49. Sigal, A., and V. Rotter. 2000. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60:6788-6793.
50. Sood, A. K., J. Coffin, J. Sarvenaz, R. E. Buller, M. J. C. Hendrix, and A. Klingelhutz. 2002. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma. Cancer Biol. Ther. 1:511-517.
51. Stansel, R. M., D. Subramanian, and J. D. Griffith. 2002. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277:11625-11628.
52. St.-Onge, L. L. Bouchard, and M. Bastin. 1993. High-frequency recombination mediated by polyomavirus large T antigen defective in replication. J. Virol. 67:1788-1795.
53. Sturzbecher, H. W., B. Donzelmann, W. Henning, U. Knippschild, and S. Buchhop. 1996, p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15:1992-2002.
54. Takai, H., A. Smogorzewska, and T. de Lange. 2003. DNA damage foci at dysfunctional telomeres, Curr. Biol. 13:1549-1556.
55. Teng, S.-C., and V. A. Zakian. 1999. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:8083-8093.
56. Tong, W. M., M. P. Hande, P. M. Lansdorp, and Z. Q. Wang. 2001. DNA strand break-sensing molecule poly(ADP-ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression. Mol. Cell. Biol. 21:4046-4054.
57. Wiesmuller, L., J. Cammenga, and W. W. Deppert. 1996. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol. 70:737-744.
58. Willers, H. E. E. McCarthy, W. Alberti, J. Dahm-Daphi, and S. N. Powell. 2000. Loss of wild-type p53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts. Int. J. Radiat. Biol. 76:1055-1062.
59. Willers, H., E. E. McCarthy, B. Wu, H. Wunsch, W. Tang, D. G. Taghian, F. Xia, and S. N. Powell. 2000. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 19:632-639.
60. Wong, K. B., B. S. DeDecker, S. M. Freund, M. R. Proctor, M. Bycroft, and A. R. Fersht. 1999. Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc. Natl. Acad. Sci. USA 96:8438-8442.
61. Wu, G., X. Jiang, W. H. Lee, and P. L. Chen. 2003. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63:2589-2595.
62. Wu, G., W. H. Lee, and P. L. Chen. 2000. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275:30618-30622.
63. Wu, L., J. H. Bayle, B. Elenbaas, N. P. Pavletich, and A. J. Levine. 1995. Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Mol. Cell. Biol. 15:497-504.
64. Yang, Q., R. Zhang, X. W. Wang, E. A. Spillare, S. P. Linke, D. Subramanian, J. D. Griffith, J. L. Li, I. D. Hickson, J. C. Shen, L. A. Loeb, S. J. Mazur, E. Appella, R. M. Brosh, Jr., P. Karmakar, V. A. Bohr, and C. C. Harris. 2002. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J. Biol. Chem. 277:31980-31987.
65. Yeager, T., A. Neumann, A. Englezou, L. Huschtscha, J. Noble, and R. Reddel. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59:4175-4179.
66. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.